Statements (50)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:genus
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:Herpesviridae
|
gptkbp:associated_with |
gptkb:healthcare_organization
|
gptkbp:contains |
gptkb:Epstein-Barr_virus
gptkb:Kaposi's_sarcoma-associated_herpesvirus |
gptkbp:discovered_by |
1960s
|
gptkbp:hosts |
gptkb:Person
primates |
https://www.w3.org/2000/01/rdf-schema#label |
Gamma herpesvirinae
|
gptkbp:is_characterized_by |
latency in lymphoid tissues
|
gptkbp:is_vulnerable_to |
no approved vaccine
|
gptkbp:propagation_method |
saliva
sexual contact |
gptkbp:related_to |
gptkb:T_cells
gptkb:psychologist gptkb:computer gptkb:herpesviridae genetic diversity public health B cells autoimmune diseases viral replication dendritic cells epigenetic regulation immunosuppression monocytes immune evasion viral load viral evolution cellular transformation viral reactivation transplant patients HIV co-infection viral latency mechanisms cytokine response latent viral infections seroprevalence |
gptkbp:research_areas |
oncology
immunology virology |
gptkbp:research_focus |
viral oncogenesis
|
gptkbp:seed_dispersal |
double-stranded DNA
|
gptkbp:social_responsibility |
opportunistic infections
|
gptkbp:symptoms |
fatigue
fever sore throat rash lymphadenopathy |
gptkbp:treatment |
antiviral medications
|